{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:05:08Z","timestamp":1791068708564,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2984,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><jats:p><jats:bold>In cirrhosis, increased RhoA\/Rho-kinase signaling and decreased nitric oxide (NO) availability contribute to increased intrahepatic resistance and portal hypertension. Hepatic stellate cells (HSCs) regulate intrahepatic resistance. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) inhibit synthesis of isoprenoids, which are necessary for membrane translocation and activation of small GTPases like RhoA and Ras. Activated RhoA leads to Rho-kinase activation and NO synthase inhibition. We therefore investigated the effects of atorvastatin in cirrhotic rats and isolated HSCs. Rats with secondary biliary cirrhosis (bile duct ligation, BDL) were treated with atorvastatin (15 mg\/kg per day for 7 days) or remained untreated. Hemodynamic parameters were determined<\/jats:bold><jats:bold>in vivo<\/jats:bold><jats:bold>(colored microspheres). Intrahepatic resistance was investigated in<\/jats:bold><jats:bold>in situ<\/jats:bold><jats:bold>perfused livers. Expression and phosphorylation of proteins were analyzed by RT-PCR and immunoblots. Three-dimensional stress-relaxed collagen lattice contractions of HSCs were performed after incubation with atorvastatin. Atorvastatin reduced portal pressure without affecting mean arterial pressure<\/jats:bold><jats:bold>in vivo<\/jats:bold><jats:bold>. This was associated with a reduction in intrahepatic resistance and reduced responsiveness of<\/jats:bold><jats:bold>in situ<\/jats:bold><jats:bold>\u2013perfused cirrhotic livers to methoxamine. Furthermore, atorvastatin reduced the contraction of activated HSCs in a 3-dimensional stress-relaxed collagen lattice. In cirrhotic livers, atorvastatin significantly decreased Rho-kinase activity (moesin phosphorylation) without affecting expression of RhoA, Rho-kinase and Ras. In activated HSCs, atorvastatin inhibited the membrane association of RhoA and Ras. Furthermore, in BDL rats, atorvastatin significantly increased hepatic endothelial nitric oxide synthase (eNOS) mRNA and protein levels, phospho-eNOS, nitrite\/nitrate, and the activity of the NO effector protein kinase G (PKG).<\/jats:bold><jats:bold>Conclusion:<\/jats:bold><jats:bold>In cirrhotic rats, atorvastatin inhibits hepatic RhoA\/Rho-kinase signaling and activates the NO\/PKG-pathway. This lowers intrahepatic resistance, resulting in decreased portal pressure. Statins might represent a therapeutic option for portal hypertension in cirrhosis. (HEPATOLOGY 2007;46:242\u2013253.)<\/jats:bold><\/jats:p><\/jats:sec>","DOI":"10.1002\/hep.21673","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T17:25:03Z","timestamp":1182965103000},"page":"242-253","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":274,"title":["Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase"],"prefix":"10.1097","volume":"46","author":[{"given":"Jonel","family":"Trebicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hennenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Laleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Shelest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Biecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schepke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20241201","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension.","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"R2-30-20241201","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-7258(01)00123-1","article-title":"Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow.","volume":"90","author":"Van de Casteele","year":"2001","journal-title":"Pharmacol Ther"},{"key":"R3-30-20241201","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/01.mcg.0000155552.14396.3d","article-title":"Portal hypertension: from bedside to bench.","volume":"39","author":"Groszmann","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R4-30-20241201","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1089-3261(05)70185-9","article-title":"Cellular and molecular basis of portal hypertension.","volume":"5","author":"Shah","year":"2001","journal-title":"Clin Liver Dis"},{"key":"R5-30-20241201","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/hep.510250102","article-title":"The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide.","volume":"25","author":"Rockey","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R6-30-20241201","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/gast.1996.v110.pm8566602","article-title":"Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells.","volume":"110","author":"Pinzani","year":"1996","journal-title":"Gastroenterology"},{"key":"R7-30-20241201","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1746.1992.tb00981.x","article-title":"Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood.","volume":"7","author":"Grossman","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-30-20241201","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.","volume":"35","author":"Wiest","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R9-30-20241201","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5085(98)70487-1","article-title":"Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.","volume":"114","author":"Rockey","year":"1998","journal-title":"Gastroenterology"},{"key":"R10-30-20241201","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gut.2005.081059","article-title":"Intrahepatic upregulation of RhoA and Rhokinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.","volume":"55","author":"Zhou","year":"2006","journal-title":"Gut"},{"key":"R11-30-20241201","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/40187","article-title":"Calcium sensitization of smooth muscle mediated by a Rhoassociated protein kinase in hypertension.","volume":"389","author":"Uehata","year":"1997","journal-title":"Nature"},{"key":"R12-30-20241201","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology.","volume":"420","author":"EtienneManneville","year":"2002","journal-title":"Nature"},{"key":"R13-30-20241201","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","article-title":"Posttranscriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.","volume":"273","author":"Laufs","year":"1998","journal-title":"J Biol Chem"},{"key":"R14-30-20241201","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, statins, and nitric oxide.","volume":"97","author":"Rikitake","year":"2005","journal-title":"Circ Res"},{"key":"R15-30-20241201","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.22.24.8467-8477.2002","article-title":"Rho GTPaseRho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase BAkt in human endothelial cells.","volume":"22","author":"Ming","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"Pt 10","key":"R16-30-20241201","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1242\/jcs.113.10.1671","article-title":"Rising behind NO: cGMPdependent protein kinases.","volume":"113","author":"Hofmann","year":"2000","journal-title":"J Cell Sci"},{"key":"R17-30-20241201","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway.","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"R18-30-20241201","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Rho GTPases and signaling networks.","volume":"11","author":"Van Aelst","year":"1997","journal-title":"Genes Dev"},{"key":"R19-30-20241201","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.279.5350.509","article-title":"Rho GTPases and the actin cytoskeleton.","volume":"279","author":"Hall","year":"1998","journal-title":"Science"},{"key":"R20-30-20241201","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"R21-30-20241201","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1159\/000088403","article-title":"Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro.","volume":"102","author":"Masterson","year":"2006","journal-title":"Nephron Exp Nephrol"},{"key":"R22-30-20241201","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0168-8278(03)00051-5","article-title":"Effect of HMGCoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells.","volume":"38","author":"Rombouts","year":"2003","journal-title":"J Hepatol"},{"key":"R23-30-20241201","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1365-2362.2003.01251.x","article-title":"Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.","volume":"33","author":"Heller","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"R24-30-20241201","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0090-9556(24)15242-7","article-title":"Metabolism and excretion of atorvastatin in rats and dogs.","volume":"27","author":"Black","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R25-30-20241201","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMGCoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"key":"R26-30-20241201","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","article-title":"A simple method to determine nanogram levels of 4hydroxyproline in biological tissues.","volume":"112","author":"Jamall","year":"1981","journal-title":"Anal Biochem"},{"key":"R27-30-20241201","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2362.2004.01331.x","article-title":"Vasodilator mRNA levels are increased in the livers of portal hypertensive NOsynthase 3deficient mice.","volume":"34","author":"Biecker","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"R28-30-20241201","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.RES.87.11.999","article-title":"Vasodilatorstimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxidecGMP signaling and endothelial dysfunction.","volume":"87","author":"Oelze","year":"2000","journal-title":"Circ Res"},{"key":"R29-30-20241201","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/j.gastro.2005.11.029","article-title":"Defective RhoARhokinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.","volume":"130","author":"Hennenberg","year":"2006","journal-title":"Gastroenterology"},{"key":"R30-30-20241201","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and 15Nnitrate in biological fluids.","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem"},{"key":"R31-30-20241201","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/jhep.2001.20793","article-title":"Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors.","volume":"33","author":"Cassiman","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R32-30-20241201","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/hep.1840200231","article-title":"Recent advances in the isolation of liver cells.","volume":"20","author":"Alpini","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R33-30-20241201","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0168-8278(02)00263-5","article-title":"Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research.","volume":"37","author":"Cassiman","year":"2002","journal-title":"J Hepatol"},{"key":"R34-30-20241201","first-page":"4827","article-title":"Evaluation of a soluble tetrazoliumformazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res"},{"key":"R35-30-20241201","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0014-4827(84)90202-7","article-title":"Effect of cyclic AMP on cellular contractility and DNA synthesis in chorioretinal fibroblasts maintained in collagen matrices.","volume":"155","author":"van Bockxmeer","year":"1984","journal-title":"Exp Cell Res"},{"key":"R36-30-20241201","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00000542-198412000-00010","article-title":"Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats.","volume":"61","author":"Seyde","year":"1984","journal-title":"Anesthesiology"},{"key":"R37-30-20241201","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-6363(96)88549-X","article-title":"Measurement of organ blood flow with coloured microspheres in the rat.","volume":"29","author":"Hakkinen","year":"1995","journal-title":"Cardiovasc Res"},{"key":"R38-30-20241201","first-page":"G52","article-title":"Portal venous pressure and portasystemic shunting in experimental portal hypertension.","volume":"257","author":"Geraghty","year":"1989","journal-title":"Am J Physiol"},{"key":"R39-30-20241201","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510280405","article-title":"Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.","volume":"28","author":"Gupta","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R40-30-20241201","first-page":"G176","article-title":"Hemodynamic characterization of chronic bile ductligated rats: effect of pentobarbital sodium.","volume":"251","author":"Lee","year":"1986","journal-title":"Am J Physiol"},{"key":"R41-30-20241201","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0168-8278(91)90812-P","article-title":"Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.","volume":"13","author":"Ruiz del Arbol","year":"1991","journal-title":"J Hepatol"},{"issue":"suppl 2","key":"R42-30-20241201","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S1590-8658(03)00053-7","article-title":"Nitric oxide and portal hypertension: a nitric oxidereleasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver.","volume":"35","author":"Fiorucci","year":"2003","journal-title":"Dig Liver Dis"},{"key":"R43-30-20241201","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0016-5085(03)00909-0","article-title":"Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.","volume":"125","author":"MoralesRuiz","year":"2003","journal-title":"Gastroenterology"},{"key":"R44-30-20241201","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/gut.51.3.440","article-title":"In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.","volume":"51","author":"Van de Casteele","year":"2002","journal-title":"Gut"},{"key":"R45-30-20241201","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/gut.25.1.73","article-title":"Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.","volume":"25","author":"Mills","year":"1984","journal-title":"Gut"},{"key":"R46-30-20241201","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005344-200307000-00018","article-title":"Acute vasodilator effects of HMGCoA reductase inhibitors: involvement of PI3kinaseAkt pathway and Kv channels.","volume":"42","author":"Mukai","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R47-30-20241201","doi-asserted-by":"crossref","first-page":"G1006","DOI":"10.1152\/ajpgi.00465.2002","article-title":"Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA.","volume":"284","author":"Murthy","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R48-30-20241201","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","article-title":"Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.","volume":"126","author":"Zafra","year":"2004","journal-title":"Gastroenterology"},{"key":"R49-30-20241201","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0168-8278(97)80473-4","article-title":"Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.","volume":"26","author":"Oberti","year":"1997","journal-title":"J Hepatol"},{"key":"R50-30-20241201","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.20671","article-title":"Statins and hepatotoxicity: focus on patients with fatty liver.","volume":"41","author":"Chalasani","year":"2005","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21673","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200707000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T22:37:22Z","timestamp":1737153442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200707000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21673","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}